Suppr超能文献

普萘洛尔和吲哚洛尔对人体血浆利多卡因清除率的影响。

Effects of propranolol and pindolol on plasma lignocaine clearance in man.

作者信息

Svendsen T L, Tangø M, Waldorff S, Steiness E, Trap-Jensen J

出版信息

Br J Clin Pharmacol. 1982;13(Suppl 2):223S-226S. doi: 10.1111/j.1365-2125.1982.tb01915.x.

Abstract

1 Steady state concentrations and clearance of lignocaine were determine in eight healthy volunteers during 360 min continuous lignocaine infusion (2 mg/min). Before the infusion propranolol (0.18 mg/kg i.v.), pindolol (0.023 mg/kg i.v.) or placebo were administered in a random double-blind, cross over design. 2 During the infusion of lignocaine heart rate, cardiac output and arterial blood pressure were measured every 60 min. 3 Propranolol decreased heart rate and cardiac output significantly by 10--20%, while pindolol or lignocaine did not change cardiac output or heart rate significantly. None of the drugs changed the arterial blood pressure. 4 Propranolol pretreatment decreased lignocaine significantly by 14.7% and the steady state concentration was increased by 22.5%. Pindolol produced no significant change in steady state concentration or clearance of lignocaine.

摘要
  1. 在8名健康志愿者持续输注利多卡因(2毫克/分钟)360分钟期间,测定了利多卡因的稳态浓度和清除率。在输注前,以随机双盲交叉设计给予普萘洛尔(0.18毫克/千克静脉注射)、吲哚洛尔(0.023毫克/千克静脉注射)或安慰剂。2. 在输注利多卡因期间,每60分钟测量一次心率、心输出量和动脉血压。3. 普萘洛尔使心率和心输出量显著降低10% - 20%,而吲哚洛尔或利多卡因对心输出量或心率无显著影响。所有药物均未改变动脉血压。4. 普萘洛尔预处理使利多卡因清除率显著降低14.7%,稳态浓度升高22.5%。吲哚洛尔对利多卡因的稳态浓度或清除率无显著影响。

相似文献

1
Effects of propranolol and pindolol on plasma lignocaine clearance in man.
Br J Clin Pharmacol. 1982;13(Suppl 2):223S-226S. doi: 10.1111/j.1365-2125.1982.tb01915.x.
2
Exercise haemodynamic effects of beta-blockade and intrinsic sympathomimetic activity.
Eur J Clin Pharmacol. 1989;36(1):5-10. doi: 10.1007/BF00561015.
3
Haemodynamic effects of atenolol, pindolol and propranolol during adrenaline infusion in man.
Eur J Clin Pharmacol. 1986;30(6):659-63. doi: 10.1007/BF00608212.
5
Effects of propranolol and pindolol on cardiac output during extended periods of low-intensity physical activity.
Am J Cardiol. 1993 Nov 15;72(15):1188-95. doi: 10.1016/0002-9149(93)90992-l.
8
The impairment of lignocaine clearance by propranolol--major contribution from enzyme inhibition.
Br J Clin Pharmacol. 1985 May;19(5):597-603. doi: 10.1111/j.1365-2125.1985.tb02686.x.
9
Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteers.
Br J Clin Pharmacol. 1985 Dec;20(6):659-67. doi: 10.1111/j.1365-2125.1985.tb05125.x.

引用本文的文献

1
beta-blockers. Drug interactions of clinical significance.
Drug Saf. 1995 Dec;13(6):359-70. doi: 10.2165/00002018-199513060-00005.
2
Effects of beta-adrenoceptor antagonists on the pharmacokinetics of lignocaine.
Br J Clin Pharmacol. 1984;17 Suppl 1(Suppl 1):21S-28S. doi: 10.1111/j.1365-2125.1984.tb02424.x.
4
The pharmacokinetics of lignocaine and beta-adrenoceptor antagonists in patients with acute myocardial infarction.
Clin Pharmacokinet. 1987 Nov;13(5):293-316. doi: 10.2165/00003088-198713050-00002.
5
The impairment of lignocaine clearance by propranolol--major contribution from enzyme inhibition.
Br J Clin Pharmacol. 1985 May;19(5):597-603. doi: 10.1111/j.1365-2125.1985.tb02686.x.
6
Effect of beta-adrenergic blockade on hormonal responses during continuous and intermittent exercise.
Cardiovasc Drugs Ther. 1989 Mar;3(1):63-71. doi: 10.1007/BF01881530.
7
Poisoning due to class 1B antiarrhythmic drugs. Lignocaine, mexiletine and tocainide.
Med Toxicol Adverse Drug Exp. 1989 Nov-Dec;4(6):412-28. doi: 10.1007/BF03259923.

本文引用的文献

2
Reduction in lidocaine clearance during continuous infusion and by coadministration of propranolol.
N Engl J Med. 1980 Aug 14;303(7):373-7. doi: 10.1056/NEJM198008143030705.
3
Adrenergic beta receptor blockade: hemodynamic importance of intrinsic sympathomimetic activity at rest.
Clin Pharmacol Ther. 1981 Jun;29(6):711-8. doi: 10.1038/clpt.1981.100.
4
Interrelationships of hepatic blood flow, cardiac output, and blood levels of lidocaine in man.
Circulation. 1971 Feb;43(2):205-11. doi: 10.1161/01.cir.43.2.205.
5
Control of the splanchnic circulation in man. Role of beta-adrenergic receptors.
Circ Res. 1967 Sep;21(3):333-40. doi: 10.1161/01.res.21.3.333.
6
Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans.
Ann Intern Med. 1973 Apr;78(4):499-508. doi: 10.7326/0003-4819-78-4-499.
7
Hemodynamic drug interactions.
Cardiovasc Clin. 1974;6(2):43-53.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验